James E. Audia

James E. Audia

Director/Board Member bij Ribon Therapeutics, Inc.

68 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

James E.
Audia
is currently the Director at Ribon Therapeutics, Inc. and a Member at Alzheimer's Association.
Previously, he served as the Independent Director at Constellation Pharmaceuticals, Inc. from 2011 to 2021.
He was also the Executive Director at Chicago Biomedical Consortium from 2017 to 2019.
Additionally, he held the position of Head-Chemistry at Karuna Therapeutics, Inc. from 2019 to 2024.
Dr. Audia obtained his doctorate degree from Yale University and the University of South Carolina.

Actieve functies van James E. Audia

BedrijvenFunctieBegin
Director/Board Member 01-04-2018
Corporate Officer/Principal 01-01-2020
Alle actieve functies van James E. Audia

Eerdere bekende functies van James E. Audia

BedrijvenFunctieEinde
KARA THER Corporate Officer/Principal 18-03-2024
CONSTELLATION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01-07-2017
Chicago Biomedical Consortium Director/Board Member 01-10-2019
Ervaring van James E. Audia in detail bekijken

Opleiding van James E. Audia

Yale University Doctorate Degree
University of South Carolina Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van James E. Audia in detail bekijken

Connecties

100 +

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit5

Commercial Services

Health Technology

Health Technology

Health Technology

Chicago Biomedical Consortium

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. James E. Audia